ProCE Banner Series

Conference to Clinic: Expert Analysis of the Top Abstracts From the 2023 Oncology Meeting in Chicago

Join us for this live, interactive webinar to hear experts discuss some of the most impactful abstracts presented during the ASCO Annual meeting and answer audience questions on the data. Full details on the available topics are provided below.

To Register: Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  AMA
Who Should Attend

This program is intended for physicians and other healthcare professionals caring for patients with cancer.

All Events

Conference to Clinic: Expert Analysis of the Top Abstracts From the 2023 Oncology Meeting in Chicago

Past Events

June

17

2023

8:00 AM - 2:55 PM Eastern Time (ET)

Virtual

Faculty

ProCE Banner Faculty
Catherine C. Coombs, MD, MS

Associate Clinical Professor of Medicine
Department of Medicine
Divsion of Oncology & Hematology
University of California, Irvine
Irvine, California

ProCE Banner Faculty
Jeff DONOTUSESharman, MD

Medical Director of Hematology Research
Willamette Valley Cancer Institute
US Oncology
Eugene, Oregon

ProCE Banner Faculty
Shaji K. Kumar, MD

Mark and Judy Mullins Professor of Hematological Malignancies
Consultant, Division of Hematology
Professor of Medicine
Mayo Clinic
Rochester, Minnesota

ProCE Banner Faculty
Leland Metheny, MD

Assistant Professor
Hematology/Oncology
University Hospitals of Cleveland
Cleveland, Ohio

ProCE Banner Faculty
Lauren Prescott, MD, MPH

Assistant Professor, Obstetrics and Gynecology
Division of Gynecologic Oncology
Vanderbilt University Medical Center
Nashville, Tennessee

ProCE Banner Faculty
Rachna Shroff, MD, MS

Professor of Medicine
Chief, Section of GI Medical Oncology
Director, UACC Clinical Trials Office
The University of Arizona Cancer Center
Tucson, Arizona

ProCE Banner Faculty
Sara M. Tolaney, MD, MPH

Assistant Professor of Medicine
Harvard Medical School
Associate Director
Susan F. Smith Center for Women’s Cancers
Director
Clinical Trials, Breast Oncology
Director
Breast Immunotherapy Clinical Research
Dana-Farber Cancer Institute
Boston, Massachusetts

ProCE Banner Faculty
Heather Wakelee, MD, FASCO

Professor of Medicine
Department of Medicine/Oncology
Stanford University
Stanford University Cancer Institute
Stanford, California 

ProCE Banner Faculty
Eunice S. Wang, MD

Chief, Leukemia and Benign Hematology Service
Professor of Oncology
Roswell Park Comprehensive Cancer Center
Buffalo, New York

ProCE Banner Faculty
Jeffrey S. Weber, MD, PhD

Professor of Medicine
NYU Grossman School of Medicine
Deputy Director
NYU Langone Health
Laura and Isaac Perlmutter Cancer Center
New York, New York

Topics

Conference to Clinic Live Virtual Webinar
Please note: All times are ET

8:05 am – 8:40 am: Gynecologic Malignancies - Lauren Prescott, MD

8:40 am – 9:25 am: Breast Cancer - Sara Tolaney, MD

9:25 – 10:25 am: Non-Accredited Educational Session:
Real World Case Discussion: Intervene with Jakafi® (Ruxolitinib) at Diagnosis in Adults with Intermediate-Risk or High-Risk Myleofibrosis - Leland Metheny, MD
Sponsored by Incyte Corporation

10:25 am – 12:00 pm: Hematologic Malignancies - Eunice Wang, MD; Jeff Sharman, MD; Shaji Kumar, MD

12:00 pm – 1:00 pm: Non-Accredited Educational Session:
Calquence - A BTKi for the Treatment of CLL/SLL with Updated Clinical Trial Data and Tablet Formulation - Catherine Callaghan Coombs, MD
Sponsored by AstraZeneca

1:00 pm – 1:45 pm: Lung Cancer - Heather A. Wakelee, MD

1:45 pm – 2:15 pm: Gastrointestinal Malignancies - Rachna Shroff, MD

2:15 pm – 2:55 pm: Melanoma and other Skin Cancers - Jeffrey Weber, MD

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to improve learners’ understanding of how to optimally apply recent practice-changing findings in treating patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer. 

Target Audience
This program is intended for physicians and other healthcare professionals caring for patients with cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify subpopulations of patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer most likely to benefit from a specific treatment plan based on predictive biomarkers
  • Apply recently presented data to clinical practice to expand treatment options and improve outcomes for patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer
  • Evaluate new data on novel agents and therapeutic approaches for patients with (Breast, Gastrointestinal, Gynecologic, Hematologic, Lung, Skin) cancer

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 0.75 Gynecologic Malignancies
  • 0.75 Breast Cancer
  • 1.50 Hematologic Malignancies
  • 0.75 Lung Cancer
  • 0.50 Gastrointestinal Malignancies
  • 0.75 Melanoma/Other Skin Cancers

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by educational grants from AbbVie, AstraZeneca, Daiichi Sankyo, Geron, Gilead, GSK, Jazz Pharmaceuticals, Lilly, Merck Sharp & Dohme Corp, Novartis, Novocure, Regeneron Pharmaceuticals, Inc., and Seagen.